Gilead Sciences Inc. (GILD)

Index:

Nasdaq 100

$ 115.76
   
  • Change Today:
    $-0.12
  • 52 Week High: $121.40
  • 52 Week Low: $79.17
  • Currency: US Dollars
  • Shares Issued: 1,246.00m
  • Volume: 278
  • Market Cap: $144,237m
  • RiskGrade: 120

Latest ShareCast News

GSK's ViiV says trial indicates HIV shot as effective as rival Gilead pill

By Frank Prenesti

Date: Thursday 23 Feb 2023

(Sharecast News) - UK pharma firm GSK's HIV treatment division, ViiV Healthcare, said its HIV injection treatment was as effective as a daily pill made by Gilead Sciences.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

GILD Market Data

Currency US Dollars
Share Price $ 115.76
Change Today $ -0.12
% Change -0.10 %
52 Week High $121.40
52 Week Low $79.17
Volume 278
Shares Issued 1,246.00m
Market Cap $144,237m
RiskGrade 120

What The Brokers Say

Strong Buy 9
Buy 12
Neutral 6
Sell 1
Strong Sell 0
Total 28
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Trades for 09-Sep-2025

Time Volume / Share Price
16:00 1,347,351 @ $115.76
15:59 100 @ $115.72
15:59 200 @ $115.72
15:59 100 @ $115.72
15:59 110 @ $115.72

Top of Page